Obesity Pipeline Review, H1 2017 - Therapeutics Report on 96 Companies & Drug Profiles - Research and Markets
Graft Versus Host Disease (GVHD) Therapeutics Pipeline Report, H1 2017: Review of 61 Companies & Their Drug Profiles - Research and Markets
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Therapeutics Pipeline Report H1 2017 - Review of 14 Companies & Drug Profiles Including Celgene, Merck & Pfizer - Research and Markets
StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.
Hepatitis C Therapy Approved in China -- WSJ
Potential "Pipeline Disruptors" - New Products That Will Drive The Future Pharmaceutical Market in Alzheimer's Disease, Asthma, Breast Cancer, Leukemia, Lung Cancer & Lymphoma - Research and Markets